Takeda ordered to pay Bayer $155M for hemophilia patent infringement FiercePharma
A jury ordered Takeda, which just scooped up Shire, to pay $155 million for patent infringement on a hemophilia drug sold by archrival Bayer.
Takeda ordered to pay Bayer $155M for hemophilia patent infringement FiercePharma
A jury ordered Takeda, which just scooped up Shire, to pay $155 million for patent infringement on a hemophilia drug sold by archrival Bayer.